Intranuclear protein transduction through a nucleoside salvage pathway.

Area of Science:

• Molecular Biology
• Cell Biology
• Drug Delivery

Background:

• Intranuclear delivery of macromolecules like transcription factors offers an alternative to gene therapy for treating diseases.
• Identifying effective delivery vehicles and pathways for macromolecules across cell and nuclear membranes remains a significant challenge.
• The anti-DNA antibody fragment 3E10 Fv shows promise as a molecular delivery vehicle due to its cell penetration, nuclear localization, and lack of toxicity.

Purpose of the Study:

• To elucidate the cellular pathway utilized by the 3E10 Fv fragment for intranuclear delivery.
• To determine if the 3E10 Fv fragment's transport mechanism can be leveraged for therapeutic applications.
• To establish a link between nucleoside transport and protein delivery into the cell nucleus.

Main Methods:

• Investigated the cellular uptake mechanism of the 3E10 Fv fragment using cells deficient in specific transporters.
• Utilized gene silencing or reconstitution of the equilibrative nucleoside transporter 2 (ENT2) to assess its role in 3E10 Fv transport.
• Confirmed nuclear localization and delivery of cargo proteins via the identified pathway.

Main Results:

• Demonstrated that 3E10 Fv penetrates cells exclusively through a nucleoside salvage transporter.
• Showed that 3E10 Fv uptake is abolished in cells lacking the equilibrative nucleoside transporter 2 (ENT2).
• Reconstitution of ENT2 in deficient cells restored 3E10 Fv transport into the cell nucleus, confirming ENT2's critical role.

Conclusions:

• The study identifies the nucleoside salvage pathway, specifically ENT2, as the mechanism for 3E10 Fv cell entry and nuclear delivery.
• This finding represents the first instance of protein transport via a nucleoside salvage pathway, opening new avenues for molecular therapies.
• The results are expected to advance gene regulation strategies for disease treatment, nucleoside salvage pathway research, and understanding autoimmune diseases.